Literature DB >> 2103733

B-cell activation and HIV-1 infection: deeds and misdeeds.

A Amadori1, L Chieco-Bianchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2103733     DOI： 10.1016/0167-5699(90)90144-x

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  29 in total

1.  Transgenic dissection of HIV genes involved in lymphoid depletion.

Authors:  B T Tinkle; H Ueda; L Ngo; P A Luciw; K Shaw; C A Rosen; G Jay
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Frequencies of HIV-reactive B cells in seropositive and seronegative individuals.

Authors:  R H Zubler; L H Perrin; A Doucet; X Zhang; Y P Huang; P A Miescher
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

3.  Molecular determinants of the human antibody response to HIV-1: implications for disease control.

Authors:  M Viau; M Zouali
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

4.  Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.

Authors:  E E Nakayama; Y Hoshino; X Xin; H Liu; M Goto; N Watanabe; H Taguchi; A Hitani; A Kawana-Tachikawa; M Fukushima; K Yamada; W Sugiura; S I Oka; A Ajisawa; H Sato; Y Takebe; T Nakamura; Y Nagai; A Iwamoto; T Shioda
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

6.  Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.

Authors:  M R Dawood; B Conway; P Patenaude; F Janmohamed; J S Montaner; M V O'Shaughnessy; G W Hammond
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

7.  Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells.

Authors:  L Chakrabarti; P Isola; M C Cumont; M A Claessens-Maire; M Hurtrel; L Montagnier; B Hurtrel
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.

Authors:  Marta Epeldegui; Dharma R Thapa; Justin De la Cruz; Scott Kitchen; Jerome A Zack; Otoniel Martínez-Maza
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

9.  Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients.

Authors:  M J Boyle; M F Berger; M Tschuchnigg; J E Valentine; B G Kennedy; M Divjak; D A Cooper; J J Turner; R Penny; W A Sewell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

10.  Murine immune response to HIV-1 p24 core protein following subcutaneous, intraperitoneal and intravenous immunization.

Authors:  L Fyfe; J Maingay; A C Robinson; S E Howie
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.